JP2005521423A5 - - Google Patents

Download PDF

Info

Publication number
JP2005521423A5
JP2005521423A5 JP2003582315A JP2003582315A JP2005521423A5 JP 2005521423 A5 JP2005521423 A5 JP 2005521423A5 JP 2003582315 A JP2003582315 A JP 2003582315A JP 2003582315 A JP2003582315 A JP 2003582315A JP 2005521423 A5 JP2005521423 A5 JP 2005521423A5
Authority
JP
Japan
Prior art keywords
temperature
virus
host cell
culture
growth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2003582315A
Other languages
English (en)
Japanese (ja)
Other versions
JP4413012B2 (ja
JP2005521423A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/009269 external-priority patent/WO2003085138A1/en
Publication of JP2005521423A publication Critical patent/JP2005521423A/ja
Publication of JP2005521423A5 publication Critical patent/JP2005521423A5/ja
Application granted granted Critical
Publication of JP4413012B2 publication Critical patent/JP4413012B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2003582315A 2002-03-29 2003-03-27 ウイルスの製造方法 Expired - Fee Related JP4413012B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36865402P 2002-03-29 2002-03-29
PCT/US2003/009269 WO2003085138A1 (en) 2002-03-29 2003-03-27 Methods of virus production

Publications (3)

Publication Number Publication Date
JP2005521423A JP2005521423A (ja) 2005-07-21
JP2005521423A5 true JP2005521423A5 (enExample) 2006-05-11
JP4413012B2 JP4413012B2 (ja) 2010-02-10

Family

ID=28791896

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003582315A Expired - Fee Related JP4413012B2 (ja) 2002-03-29 2003-03-27 ウイルスの製造方法

Country Status (9)

Country Link
US (1) US7344873B2 (enExample)
EP (1) EP1492891B1 (enExample)
JP (1) JP4413012B2 (enExample)
AT (1) ATE386824T1 (enExample)
AU (1) AU2003226012B2 (enExample)
CA (1) CA2478901A1 (enExample)
DE (1) DE60319210T2 (enExample)
ES (1) ES2299715T3 (enExample)
WO (1) WO2003085138A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2521496T3 (es) 2007-05-04 2014-11-12 Baxter International Inc. Perfil de temperatura en dos etapas para la propagación de virus
BR112012026095A2 (pt) 2010-04-14 2015-09-15 Emd Millipore Corp métodos de produção de estoques de vírus de alta pureza e altos títulos e métodos de uso dos mesmos.
US20110262965A1 (en) 2010-04-23 2011-10-27 Life Technologies Corporation Cell culture medium comprising small peptides
US9879229B2 (en) 2011-03-14 2018-01-30 National Research Council Of Canada Method of viral production in cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3962424A (en) * 1974-01-31 1976-06-08 Recherche Et Industrie Therapeutiques (R.I.T.) Live brovine adenovirus vaccines, preparation thereof and method of vaccination using them
US5618714A (en) 1993-12-15 1997-04-08 Eli Lilly And Company Methods for producing protein C
US5837520A (en) * 1995-03-07 1998-11-17 Canji, Inc. Method of purification of viral vectors
EP1445322B2 (en) * 1995-06-15 2012-06-06 Crucell Holland B.V. Packaging systems for human recombinant adenovirus to be used in gene therapy
EP1200622A4 (en) 1999-07-06 2004-12-22 Merck & Co Inc HIV VACCINE FROM AN ADENOVIRUS CARRYING THE GAG GENE
CA2422882A1 (en) 2000-09-15 2002-03-21 Merck & Co., Inc. Enhanced first generation adenovirus vaccines expressing codon optimized hiv1-gag, pol, nef and modifications

Similar Documents

Publication Publication Date Title
JP2003526362A5 (enExample)
JP2009034115A5 (enExample)
CY1114598T1 (el) Μεθοδος για την ενισχυση ενος ιου φυσαλιδωδους νοσου υπο συνθηκες ελευθερες ορου
JP2005502357A5 (enExample)
DE60017234D1 (de) Vakzinproduktion
JP2006519023A5 (enExample)
CN107267532A (zh) PEDV JS2008株全长感染性cDNA的构建方法及应用
JP2005521423A5 (enExample)
CN107926706B (zh) 迷你蝴蝶兰脱毒苗的组织培养方法
CN117327664A (zh) 一种热稳定的柯萨奇病毒a组6型病毒株及其应用
CN103436520A (zh) 一种以酿酒酵母孢子为载体的新型固定化酶的制备方法
CN102911920A (zh) Ⅱ型登革病毒kmb17细胞适应株及其制备方法
RU2191600C1 (ru) Способ получения антирабической вакцины
JP2019511208A5 (enExample)
WO2025067282A1 (zh) 一种耐热柯萨奇病毒a组10型热稳定株及其应用
CN101899422B (zh) 轮状病毒p[2]g3株和p[8]g1株在kmb17细胞上适应培养方法和免疫原性
Liu et al. Complete genome sequences of three sub-genotype 2.1 b isolates of classical swine fever virus in China
CA2687122C (en) Two-step temperature profile for the propagation of viruses
CN106148289A (zh) 一种纯化戊型肝炎病毒的方法
EP1492891A4 (en) PROCESS FOR VIRUS PRODUCTION
CN119350456B (zh) HC-Pro蛋白的突变体及其在防治番木瓜环斑病毒中的应用
CN1644686A (zh) 流感病毒哺乳动物细胞高产毒株、其重组毒株及其制备方法和应用
CN111778273A (zh) 菊叶薯蓣转基因毛状根诱导方法
CN1075335A (zh) 性状转变的抗稻属叶条纹病病毒性稻属及其制造方法
CN103695377A (zh) I型登革病毒kmb17细胞适应株的培育及其制备方法